feed,title,long_url,short_url
InsiderMonkey,"Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries",https://insidermonkey.com/blog/--1601762,
InsiderMonkey,Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential,https://insidermonkey.com/blog/--1601766,
InsiderMonkey,Bristol-Myers Squibb Company (BMY) Launches $300M Immunology Spinout with Bain Capital,https://insidermonkey.com/blog/--1601768,
InsiderMonkey,"Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy",https://insidermonkey.com/blog/--1601770,
InsiderMonkey,"Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand",https://insidermonkey.com/blog/--1601772,
InsiderMonkey,"Pfizer Inc. (PFE)’s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide",https://insidermonkey.com/blog/--1601774,
InsiderMonkey,"AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market",https://insidermonkey.com/blog/--1601776,
InsiderMonkey,"Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028",https://insidermonkey.com/blog/--1601780,
InsiderMonkey,Johnson & Johnson (JNJ)’s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth,https://insidermonkey.com/blog/--1601784,
InsiderMonkey,Eli Lilly and Company (LLY) Halts UK Mounjaro Shipments Ahead of Planned Price Increase,https://insidermonkey.com/blog/--1601787,
InsiderMonkey,Microsoft (MSFT) Expands AI Capabilities With MAI-Voice-1 and MAI-1-Preview Testing,https://insidermonkey.com/blog/--1601485,
InsiderMonkey,Broadcom (AVGO) Enhances VMware Cloud Foundation With AI Services and Data Intelligence Launch,https://insidermonkey.com/blog/--1601481,
InsiderMonkey,"Cloudflare (NET) Integrates With ChatGPT, Claude, Gemini to Boost Generative AI Security",https://insidermonkey.com/blog/--1601279,
InsiderMonkey,Goldman Sachs Reaffirms Synopsys (SNPS) Buy Rating Amid Ansys Merger Uncertainty,https://insidermonkey.com/blog/--1601728,
InsiderMonkey,TD Cowen Confident in Workday’s (WDAY) Fiscal 2026 Revenue Outlook,https://insidermonkey.com/blog/--1601733,
InsiderMonkey,Analysts Bullish on Palo Alto (PANW) as ARR Target of $15B by 2030 Remains on Track,https://insidermonkey.com/blog/--1601739,
InsiderMonkey,UBS Maintains Autodesk (ADSK) Buy Rating Amid Strong Q2 Revenue and Billings Growth,https://insidermonkey.com/blog/--1601730,
InsiderMonkey,KBW Highlights Upside Potential for Block (XYZ) Across Its Business Segments,https://insidermonkey.com/blog/--1601750,
InsiderMonkey,UBS Maintains Fiscal 2025 Projections for Adobe (ADBE) Despite Target Cut,https://insidermonkey.com/blog/--1601755,
InsiderMonkey,KeyBanc Maintain Positive Bias on Intuit (INTU) Despite Tighter Pricing Comparisons,https://insidermonkey.com/blog/--1601761,
